Capital Bank & Trust’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
– Sell
-48
Closed -$3K – 386
2020
Q1
$3K Buy
+48
New +$2.99K ﹤0.01% 611
2018
Q4
– Sell
-36
Closed -$1K – 737
2018
Q3
$1K Hold
36
– – ﹤0.01% 784
2018
Q2
$1K Hold
36
– – ﹤0.01% 659
2018
Q1
$1K Hold
36
– – ﹤0.01% 626
2017
Q4
$1K Buy
+36
New +$468 ﹤0.01% 670

Other funds holding DXCM

Capital Bank & Trust's DXCM Position: Q2 2020 in Review

Capital Bank & Trust sold out of DexCom (DXCM) in Q2 2020, closing a stake of 48 shares — an estimated $3K sold.

Capital Bank & Trust first reported a position in DXCM in Q4 2017 and held it in 5 quarters. The position peaked at $3K in Q1 2020. 723 funds tracked by Wall St. Rank hold DXCM as of Q2 2020.

  • Capital Bank & Trust reported no remaining DexCom position as of Q2 2020 after selling out during the quarter.
  • Capital Bank & Trust sold 48 DexCom shares in Q2 2020, an estimated $3K.
  • Capital Bank & Trust first reported a position in DexCom in Q4 2017 and held it in 5 quarters.
  • Capital Bank & Trust's DexCom position peaked at $3K in Q1 2020.
  • 723 funds tracked by Wall St. Rank held DexCom as of Q2 2020.

Based on Capital Bank & Trust's 13F filing for Q2 2020, filed 14 Aug 2020.